Alkermes (ALKS) Receivables - Other (2015 - 2025)
Alkermes (ALKS) reported Receivables - Other of $717000.0 for Q3 2025, down 75.85% year-over-year from $3.0 million in Q3 2024, and down 49.65% quarter-over-quarter from $1.4 million in Q2 2025.
Alkermes (ALKS) Receivables - Other (2015 - 2025) Analysis & Trends
Alkermes (ALKS) has 11 years of Receivables - Other data on file, last reported at $717000.0 in Q3 2025.
- Receivables - Other for Q3 2025 came in at $717000.0, down 75.85% year-over-year; the trailing twelve-month figure through Sep 2025 was $717000.0 (down 75.85% YoY), and the FY2024 annual result was $5.0 million, up 606.8% from the prior year.
- Receivables - Other fell to $717000.0 in Q3 2025 per ALKS's latest filing, from $1.4 million in the prior quarter.
- Over five years, Receivables - Other peaked at $16.5 million in Q2 2022 and troughed at $100000.0 in Q1 2022.
- A 5-year average of $6.4 million and a median of $4.2 million in 2024 frame the typical range for Receivables - Other.
- The sharpest annual moves came in 2022 and 2023: Receivables - Other slumped 99.3% in 2022, then surged 8329.0% in 2023.
- A 5-year view of Receivables - Other shows it stood at $13.4 million in 2021, then slumped by 33.18% to $8.9 million in 2022, then slumped by 92.09% to $706000.0 in 2023, then jumped by 606.8% to $5.0 million in 2024, then slumped by 85.63% to $717000.0 in 2025.
- Business Quant data shows ALKS's Receivables - Other at $717000.0 in Q3 2025, $1.4 million in Q2 2025, and $3.0 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 717,000.00 |
| Sep 30, 2025 | 717,000.00 |
| Jun 30, 2025 | 1.42 Mn |
| Jun 30, 2025 | 1.42 Mn |
| Mar 31, 2025 | 3.05 Mn |
| Mar 31, 2025 | 3.05 Mn |
| Dec 31, 2024 | 4.99 Mn |
| Dec 31, 2024 | 4.99 Mn |
| Sep 30, 2024 | 2.97 Mn |
| Sep 30, 2024 | 2.97 Mn |
| Jun 30, 2024 | 3.49 Mn |
| Jun 30, 2024 | 3.49 Mn |
| Mar 31, 2024 | 1.23 Mn |
| Mar 31, 2024 | 1.23 Mn |
| Dec 31, 2023 | 706,000.00 |
| Dec 31, 2023 | 706,000.00 |
| Sep 30, 2023 | 2.77 Mn |
| Sep 30, 2023 | 2.77 Mn |
| Mar 31, 2023 | 8.43 Mn |
| Mar 31, 2023 | 8.43 Mn |